GlassScriptPhysician profile
Raymond Folmar
NPI 1538243308
$69,634.72
in general payments reported to CMS, 2019-2025
14 companies · $40.38 in 2025
The $40.38 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $23K · 2021: $13K · 2022: $99.81 · 2023: $21.78 · 2024: $6,062 · 2025: $40.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,000 · Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,000.00 |
| Food and Beverage | $124.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Orthopaedic Solutions, INC. | $35,900.00 | 2019-2020 | |
| Medacta USA, INC. | $14,284.69 | 2019-2020 | |
| Arthrex, INC. | $12,900.00 | 2021 | |
| Citieffe, INC. | $6,000.00 | 2024 | |
| Stryker Corporation | $188.96 | 2019-2024 | Asnis, Hydroset, Vitoss |
| Zimmer Biomet Holdings, INC. | $93.73 | 2020-2021 | |
| Djo, LLC | $87.41 | 2022 | |
| Becton, Dickinson and Company | $45.09 | 2024 | Arista Ah Flexitip |
| Biocomposites INC | $40.38 | 2025 | Stimulan |
| Endo Pharmaceuticals INC. | $26.49 | 2020-2022 | |
| Medtronic USA, INC. | $20.07 | 2019 | |
| Convatec INC. | $18.65 | 2019 | |
| Maxx Health INC | $14.87 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Folmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.